337 related articles for article (PubMed ID: 22847511)
21. Diabetes, metformin, and breast cancer in postmenopausal women.
Chlebowski RT; McTiernan A; Wactawski-Wende J; Manson JE; Aragaki AK; Rohan T; Ipp E; Kaklamani VG; Vitolins M; Wallace R; Gunter M; Phillips LS; Strickler H; Margolis K; Euhus DM
J Clin Oncol; 2012 Aug; 30(23):2844-52. PubMed ID: 22689798
[TBL] [Abstract][Full Text] [Related]
22. Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis.
Tian RH; Zhang YG; Wu Z; Liu X; Yang JW; Ji HL
Clin Transl Oncol; 2016 Jun; 18(6):641-9. PubMed ID: 26459254
[TBL] [Abstract][Full Text] [Related]
23. A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus.
Bradley MC; Ferrara A; Achacoso N; Ehrlich SF; Quesenberry CP; Habel LA
Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):525-530. PubMed ID: 29716927
[No Abstract] [Full Text] [Related]
24. Colon neoplasia in patients with type 2 diabetes on metformin: A meta-analysis.
Rokkas T; Portincasa P
Eur J Intern Med; 2016 Sep; 33():60-6. PubMed ID: 27318643
[TBL] [Abstract][Full Text] [Related]
25. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
26. [Metformin, an antidiabetic molecule with anti-cancer properties].
Beck E; Scheen AJ
Rev Med Liege; 2013 Sep; 68(9):444-9. PubMed ID: 24180199
[TBL] [Abstract][Full Text] [Related]
27. A prospective study of type 2 diabetes, metformin use, and risk of breast cancer.
Park YM; Bookwalter DB; O'Brien KM; Jackson CL; Weinberg CR; Sandler DP
Ann Oncol; 2021 Mar; 32(3):351-359. PubMed ID: 33516778
[TBL] [Abstract][Full Text] [Related]
28. The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta-analysis.
Xiao K; Liu F; Liu J; Xu J; Wu Q; Li X
J Clin Pharm Ther; 2020 Aug; 45(4):783-792. PubMed ID: 32406122
[TBL] [Abstract][Full Text] [Related]
29. Effect of metformin use on the risk and prognosis of colorectal cancer in diabetes mellitus: a meta-analysis.
Wang Q; Shi M
Anticancer Drugs; 2022 Feb; 33(2):191-199. PubMed ID: 34620743
[TBL] [Abstract][Full Text] [Related]
30. Diabetes mellitus is associated with breast cancer: systematic review, meta-analysis, and in silico reproduction.
Zhou Y; Zhang X; Gu C; Xia J
Panminerva Med; 2015 Sep; 57(3):101-8. PubMed ID: 25971328
[TBL] [Abstract][Full Text] [Related]
31. Metformin use and prostate cancer risk: A meta-analysis of cohort studies.
Feng Z; Zhou X; Liu N; Wang J; Chen X; Xu X
Medicine (Baltimore); 2019 Mar; 98(12):e14955. PubMed ID: 30896668
[TBL] [Abstract][Full Text] [Related]
32. Associations of metformin therapy treatment with endometrial cancer risk and prognosis: A systematic review and meta-analysis.
Xie H; Li M; Zheng Y
Gynecol Oncol; 2024 Mar; 182():15-23. PubMed ID: 38246042
[TBL] [Abstract][Full Text] [Related]
33. Long-term metformin use is associated with decreased risk of breast cancer.
Bodmer M; Meier C; Krähenbühl S; Jick SS; Meier CR
Diabetes Care; 2010 Jun; 33(6):1304-8. PubMed ID: 20299480
[TBL] [Abstract][Full Text] [Related]
34. Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis.
Zhang ZJ; Zheng ZJ; Shi R; Su Q; Jiang Q; Kip KE
J Clin Endocrinol Metab; 2012 Jul; 97(7):2347-53. PubMed ID: 22523334
[TBL] [Abstract][Full Text] [Related]
35. Metformin use and risk of fracture: a systematic review and meta-analysis of observational studies.
Salari-Moghaddam A; Sadeghi O; Keshteli AH; Larijani B; Esmaillzadeh A
Osteoporos Int; 2019 Jun; 30(6):1167-1173. PubMed ID: 30927035
[TBL] [Abstract][Full Text] [Related]
36. The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes.
Vissers PA; Cardwell CR; van de Poll-Franse LV; Young IS; Pouwer F; Murray LJ
Breast Cancer Res Treat; 2015 Apr; 150(2):427-37. PubMed ID: 25762476
[TBL] [Abstract][Full Text] [Related]
37. Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
Liu F; Yan L; Wang Z; Lu Y; Chu Y; Li X; Liu Y; Rui D; Nie S; Xiang H
Oncotarget; 2017 Feb; 8(9):16017-16026. PubMed ID: 27926481
[TBL] [Abstract][Full Text] [Related]
38. Association between metformin therapy and incidence, recurrence and mortality of prostate cancer: evidence from a meta-analysis.
Deng D; Yang Y; Tang X; Skrip L; Qiu J; Wang Y; Zhang F
Diabetes Metab Res Rev; 2015 Sep; 31(6):595-602. PubMed ID: 25708557
[TBL] [Abstract][Full Text] [Related]
39. Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark.
Bosco JL; Antonsen S; Sørensen HT; Pedersen L; Lash TL
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):101-11. PubMed ID: 21119073
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
